Wigginton Jon Marc Insider Trades

Insider Trading History

Track insider trading activity for Wigginton Jon Marc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sutro Biopharma
Sutro Biopharma STRO
Director
Holding Value $40.8k 1,500 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.6k 1,500 shares
$10.38
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Director
Holding Value $1.36M 50,000 shares
Last Trade
Jun 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 50,000 shares
$0.85
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Director
Holding Value $951k 35,000 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 35,000 shares
$3.76
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Director
Holding Value $680k 25,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 25,000 shares
$5.12
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Director
Holding Value $503k 18,500 shares
Last Trade
Jun 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.1k 18,500 shares
$4.44
$27.18
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Director
Holding Value $0 0 shares
Last Trade
May 31, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$211k 20,061 shares
$10.50
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Director
Holding Value $211k 20,061 shares
Last Trade
Jan 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.9k 20,061 shares
$2.19
$10.50
Sutro Biopharma
Sutro Biopharma STRO
Director
Holding Value $503k 18,500 shares
Last Trade
Jun 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$337k 18,500 shares
$18.21
$27.18
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Chief Medical Officer
Holding Value $1.77M 116,666 shares
Last Trade
Jan 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.33k 116,666 shares
$0.02
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jan 07, 2021 Sale
$5.06k 252,891 shares
$0.02
$15.21
Sutro Biopharma
Sutro Biopharma STRO
Director
Holding Value $652k 24,000 shares
Last Trade
Nov 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 24,000 shares
$17.10
$27.18
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $420k 100,000 shares
Last Trade
Feb 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 100,000 shares
$11.50
$4.20
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $378k 90,000 shares
Last Trade
Feb 21, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 90,000 shares
$21.88
$4.20
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $294k 70,000 shares
Last Trade
Mar 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.03M 70,000 shares
$28.94
$4.20
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $79.5k 18,930 shares
Last Trade
Feb 26, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$260k 11,070 shares
$23.46
$4.20
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $137k 32,524 shares
Last Trade
Jan 17, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$50.1k 2,524 shares
$19.85
$4.20
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $191k 45,448 shares
Last Trade
Jan 17, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$50.1k 2,524 shares
$19.85
$4.20
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $126k 30,000 shares
Last Trade
Jan 17, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$50.5k 2,524 shares
$20.00
$4.20
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $136k 32,476 shares
Last Trade
Jan 16, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49k 2,476 shares
$19.78
$4.20
Macrogenics
Macrogenics MGNX
Sr Vp, Clinical Dev. & CMO
Holding Value $201k 47,972 shares
Last Trade
Jan 16, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49k 2,476 shares
$19.78
$4.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up